AnaptysBio, Inc. Common Stock (ANAB) is a publicly traded Healthcare sector company. As of July 28, 2026, ANAB trades at $53.03 with a market cap of $1.60B and a P/E ratio of -58.09. ANAB moved -1.34% today. Year to date, ANAB is +10.58%; over the trailing twelve months it is +99.00%. Its 52-week range spans $12.21 to $73.30. Analyst consensus is strong buy with an average price target of $80.67. Rallies surfaces ANAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ANAB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $53.03 |
| Market Cap | $1.60B |
| P/E Ratio | -58.09 |
| EPS | $-0.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $73.30 |
| 52-Week Low | $12.21 |
| Volume | 179.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $232.39M |
| Net Income | $-26.79M |
| Gross Margin | 0.00% |
7 analysts cover ANAB: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $80.67.